Clinical Trial Update: Clinical Trial to Assess the Efficacy and Safety of YYC405 in Type 2 Diabetes Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating YYC405 for efficacy and safety in Type 2 Diabetes is ongoing with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• YYC405

Snippet

Sponsor: Yooyoung Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: UNKNOWN